The list of centres authorized by the Italian regions to the prescription of drugs for the treatment of hepatitis C has been updated again.
The update was done on February 18th 2015 and involved the active substances telaprevir, boceprevir, and sofosbuvir. The list of centres authorized to the prescription of drugs for the treatment of atypical uremic hemolytic syndrome has also been updated. The update was done on February 18th 2015 and involved the active substance eculizumab.
